ANAPA BIOTECH A/S: Financial statements 2017
CVR: 27585167
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ANAPA BIOTECH A/S (CVR 27585167) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 360,000 and a net result of DKK -5,166,000 compared with DKK -27,023,000 the year before. Equity in the 2017 report amounted to DKK 4,507,000. The solvency ratio was 92.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 360,000
- Profit/Loss
- DKK -5,166,000
- Equity
- DKK 4,507,000
- Total Assets
- DKK 4,878,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 360K | -5.2M | 4.5M | 1 |
| 2016 | - | -219K | -27M | 9.7M | 1 |
| 2015 | - | -589K | -14.4M | 36.7M | 2 |
| 2014 | - | -1.3M | -1.8M | 51.1M | 5 |
| 2013 | - | -2.4M | -2.8M | 50.7M | 7 |
Official annual report
Keep an eye on ANAPA BIOTECH A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ANAPA BIOTECH A/S has published its annual report for 2016. Gross profit came to DKK -219,000, and the net result was DKK -27,023,000.
About ANAPA BIOTECH A/S
ANAPA BIOTECH A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named QUANTIBACT A/S and LNA BACTERIAL DETECTION A/S. The management consists of Søren Morgenthaler Echwald. The board consists of Anette Kofod Echwald (chair), Caroline Marie Morgenthaler Echwald and Søren Morgenthaler Echwald. The company is owned by Apana Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 263,027 and a net result of DKK 488,982 compared with DKK 7,646,635 the year before. Equity in the 2025 report amounted to DKK 10,970,173.